BIM
ABBV icon

Bullseye Investment Management’s AbbVie ABBV Stock Holding History

Bullseye Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$170K Buy
+676
New +$145K 0.08% 76
2022
Q3 		– Sell
-8,539
Closed -$1.31M – 38
2022
Q2 		$1.31M Buy
8,539
+7,294
+586% +$1.11M 1.17% 20
2022
Q1 		$202K Buy
+1,245
New +$181K 0.17% 48

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bullseye Investment Management's ABBV Position: Q2 2026 in Review

Bullseye Investment Management opened a new position in AbbVie (ABBV) in Q2 2026: 676 shares worth $170K. The stake represents 0.08% of the portfolio and ranks #76 among its holdings. This is a return to the name: Bullseye Investment Management previously reported a position in ABBV as recently as Q2 2022.

Bullseye Investment Management first reported a position in ABBV in Q1 2022 and has held it in 3 quarters since. The position peaked at $1.31M in Q2 2022. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Bullseye Investment Management held 676 shares of AbbVie worth $170K as of Q2 2026.
  • AbbVie was a new Bullseye Investment Management position in Q2 2026.
  • AbbVie made up 0.08% of Bullseye Investment Management's portfolio in Q2 2026, its #76 holding.
  • Bullseye Investment Management first reported a position in AbbVie in Q1 2022 and has held it in 3 quarters since.
  • Bullseye Investment Management's AbbVie position peaked at $1.31M in Q2 2022.
  • 4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Bullseye Investment Management's 13F filing for Q2 2026, filed 11 Sep 2026.